Agios Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AGIO Nasdaq 2830 www.agios.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Agios Pharmaceuticals, Inc.

Agios Sinks 18% as FDA Delays Sickle Cell Drug Decision to 2027 Despite Being “Launch-Ready” - Oct 30th, 2026 9:56 am
Agios Announces New PDUFA Goal Date of February 1, 2027, for Mitapivat Sickle Cell Disease sNDA; Company Is Launch-Ready and in Labeling Discussions with FDA - Oct 30th, 2026 5:00 am
Agios Pharmaceuticals (AGIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Oct 29th, 2026 7:00 am
LENZ Therapeutics, Inc. (LENZ) Reports Q3 Loss, Misses Revenue Estimates - Oct 28th, 2026 2:45 pm
DHR Q3 Earnings Beat on Biotechnology Strength, Sales in Line - Oct 21st, 2026 7:45 am
Did Priority Review Just Shift Agios Pharmaceuticals' (AGIO) Investment Narrative? - Oct 20th, 2026 5:23 pm
A Phase 3 Win and a 130% Takeover Premium Lit Up Rare Blood-Disease Stocks on Monday - Oct 20th, 2026 6:59 am
FDA Decision Watch: What Investors Need To Know About Four Upcoming Drug Rulings - Oct 19th, 2026 3:43 am
Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock? - Oct 16th, 2026 6:41 am
4 High-Risk Stocks Built for Big Returns - Oct 14th, 2026 4:28 am
Agios Pharmaceuticals (AGIO) Could Be 28% Undervalued Following Its November Results Call Date - Oct 9th, 2026 8:12 pm
Agios Pharmaceuticals (AGIO) Stock Looks Fully Priced Against Current Sales - Oct 9th, 2026 4:08 pm
Agios to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5 at 8:00 a.m. ET - Oct 8th, 2026 5:00 am
AGIO Stock Sinks 29% in Three Months: Here's What You Need to Know - Oct 6th, 2026 7:55 am
Agios' Growth Story Hinges on Mitapivat's Commercial Expansion - Oct 2nd, 2026 7:22 am
Revolution Medicines (RVMD) Up 6.6% Since Last Earnings Report: Can It Continue? - Sep 4th, 2026 9:30 am
AGIO Q2 Earnings Beat Estimates, Revenues Increase Year Over Year - Jul 31st, 2026 10:17 am
Agios Pharmaceuticals Inc (AGIO) (Q2 2026) Earnings Call Highlights: Strong Mitapivat Revenue ... - Jul 30th, 2026 1:02 pm
Agios Pharmaceuticals Q2 Earnings Call Highlights - Jul 30th, 2026 8:04 am
Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Beats Revenue Estimates - Jul 30th, 2026 5:50 am